Multiple myeloma—translation of trial results into reality
- 1 July 2016
- journal article
- Published by Elsevier in The Lancet
- Vol. 388 (10040) , 111-113
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Multiple Myeloma: Diagnosis and TreatmentMayo Clinic Proceedings, 2016
- Myeloma today: Disease definitions and treatment advancesAmerican Journal of Hematology, 2015
- Interpretation of cytogenetic results in multiple myeloma for clinical practiceBlood Cancer Journal, 2015
- Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple MyelomaJournal of Clinical Oncology, 2015
- Multiple Myeloma: From Front-Line to Relapsed TherapiesAmerican Society of Clinical Oncology Educational Book, 2015
- Why Are Cancer Drugs So Expensive in the United States, and What Are the Solutions?Mayo Clinic Proceedings, 2015
- Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsLeukemia, 2013
- A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaBlood, 2012
- Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogeneticsBlood, 2012
- Need to realign patient-oriented and commercial and academic researchThe Lancet, 2011